A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer

By Coleman R.E.   Houston S.   Purohit O.P.   Rubens R.D.   Kandra A.   Ford J.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 820-824

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Clarithromycin and Pamidronate Therapy in Myeloma

By Morris T.C.M.   Ranaghan L.   Morrison J.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 79-84

Humana Press, Inc

Access to resources Recommend Favorite

Does Supportive Pamidronate Treatment Prevent or Delay the First Manifestation of Bone Metastases in Breast Cancer Patients?

By van Holten-Verzantvoort A.T.M.   Hermans J.   Beex L.V.A.M.   Blijham G.   Cleton F.J.   van Eck-Smit B.C.F.   Sleeboom H.P.   Papapoulos S.E.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 450-454

Elsevier

Access to resources Recommend Favorite

Half body irradiation of patients with multiple bone metastases: A phase II trial

By Berg Randi   Yilmaz Mette   Høyer Morten   Keldsen Nina   Nielsen Ole   Ewertz Marianne  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 556-561

Informa Healthcare

Access to resources Recommend Favorite

A Phase II Study of Single Agent Bortezomib in Patients with Metastatic Breast Cancer: A Single Institution Experience

By Engel Ryan   Brown Jennifer   Von Roenn Jamie   O'Regan Ruth   Bergan Raymond   Badve Sunil   Rademaker Alfred   Gradishar William  

Cancer Investigation, Vol. 25, Iss. 8, 2007-10 ,pp. : 733-737

Informa Healthcare

Access to resources Recommend Favorite